NOVEL THERAPEUTIC APPROACHES
BRIDGING RESEARCH AND IMPLEMENTATION
The NOVAHealth launches the Conference “Novel Therapeutic Approaches: Bridging Research and Implementation”, which will take place on November 25th, 2026, at the Rectory Auditorium of Universidade Nova de Lisboa.
This conference brings together researchers to explore breakthroughs in precision medicine, cell therapies, and disease treatment.
The academic community and NOVAHealth partners are invited.
SYNOPSIS
Advances in biomedical research are transforming the landscape of disease prevention, diagnosis, and treatment. From innovative drug discovery platforms and precision medicine to cell and gene therapies, novel therapeutic approaches are offering unprecedented opportunities to address some of the most pressing health challenges of our time. However, translating scientific breakthroughs into effective, accessible, and sustainable healthcare solutions remains a complex and multidisciplinary endeavour.
This one-day conference, Novel Therapeutic Approaches: Bridging Research and Implementation, will bring together biomedical and clinical researchers to explore the latest developments in therapeutic innovation across infectious, cancer and chronic diseases. The programme will highlight cutting-edge research findings, emerging technologies, and successful translational strategies that may shape the future of patient care.
.
REGISTRATION & SUBMISSIONS
Authors interested in presenting their original research, clinical studies, translational projects, innovative mathodologies or case studies relevant to the conference theme, may do so on the dates indicated below, following the respective recommendations and instructions. Instructions and selection criteria in the call for abstracts, posters or oral presentation.
The best poster will be rewarded with a prize.
CONFERENCE REGISTRATION
Deadline: November 13th, 2026
ABSTRACT SUBMISSION
Deadline: October 23th, 2026
CONFIRMATION OF ACCEPTANCE
Deadline: November 6th, 2026
Any additional questions send an email to novasaude@unl.pt
PROGRAM
9.00h: Professor Paulo Pereira | Rector of Universidade Nova de Lisboa –
Professor Emília Monteiro | Vice-Rector for Education, Academic Life, Health and Quality
Opening Remarks
9.10h: SESSION 1 – Professor Bruno Silva-Santos| Faculdade de Medicina da Universidade de Lisboa (FMUL) – Engineered and combination strategies for Delta One T cells in colorectal cancer
9.40h: Professor Pedro Viana Baptista|NOVA School of Science and Technology (FCT)
9.50h: Professor Doutor Pedro Antas|NOVA Medical School (NMS) – CRISPR-based gene editing for Choroideremia
10.00h: Speaker 3|NOVA National School of Public Health
10.10h: Speaker 4 [Abstract Selecter]
10.20h: Roundtable with Talk Speakers
10.45h: Coffee Break
11.15h: Professor Raquel Sá Leão|NOVA Institute of Chemical and Biological Technology
11.25h: Professor Gustavo Cassiano|NOVA Institute of Hygiene and Tropical Medicine (IHMT) – Machine learning-guided discovery of antimalarials active across multiple parasite stages
11.35h – Speaker 8 [Abstract Selecter]
12.15h: Lunch
13.30h: SESSION 2 – Professor Pedro Góis
14.00h: Professor Maria João Romão|NOVA School of Science and Technology
14.10h: Professor João Conde|NOVA Medical School – The power of nanoMedicine
14:20: Speaker 11|NOVA National School of Public Health
14.30h: Speaker 12|NOVA Institute of Chemical and Biological Technology
14.40h – Speaker 13 [Abstract Selecter]
14.50h: Roundtable with Talk Speakers
15.10h: Coffee Break
15.40h: Professor Sofia Santos Costa|NOVA Institute of Hygiene and Tropical Medicine (IHMT) – From in vitro hits to in vivo screening: Galleria mellonella as an alternative early-stage infection model
15.50h: Speaker 15 [Abstract Selecter]
16.00h: [To Define]
16.10h: Roundtable with Talk Speakers
16.30h: Best Poster Award
16.40h: Concluding Remarks
SPEAKERS
ORGANIZING COMMITTEE
OUR CONFERENCES
NOVAHEALTH – STRATEGIC AREAS
NOVAHEALTH – Chronic and Infectious Diseases
Chronic and infectious diseases are one of the major global human health problems that include neurodegeneration, inflammation, immunological dysregulation, and old and emerging microbial infectious diseases. Chronic diseases have been leveraged by the longer human lifespan, while globalization, migrations, exponential increasing of travellers have been associated with an alarming escalade of microbes that are resistant to antibiotics. NOVA Saúde Chronic Disease and Infection Group promotes research, evidence-based knowledge and awareness to develop new effective and sustainable approaches and solutions to these problems. The group fosters academic and social discussion in order to respond to the daily challenges pose to patients, as well as, to the health systems and their professionals.
NOVAHEALTH – Drug Discovery and Advanced Therapies
Ttthe discovery and development of drugs, biopharmaceuticals, and advanced therapies are essential for identifying new or improved treatments for human diseases. In this context, the concerted and integrative application of scientific knowledge, cutting-edge technologies, and collaborative efforts are vital to finding, designing, testing, optimizing, and developing bioprocesses for novel medicines that can prevent symptoms and cure various medical conditions.
